Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063804

President and CEO gave up 833 shares (to pay taxes)

  • President and CEO acquired 2,925 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Walker Neal · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-12-18 Exercise or conversion : show line 1 in the form +2,925 910,957 D
2018-12-18 Shares withheld for taxes : show line 2 in the form −833 $6.30 $5,248 910,124 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-12-18 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,925 2,925 D
Loading xslF345X03/doc4.xml…